RxDoctor Payments DataLook up a doctor →

Michael Guarino

Medical Oncology · Newark, DENPI 1316916349

Payments from drug & device makers

$2,374,308in general payments, 2019–2025

Across 723 payments — averaging $3283.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$968K
  • Seagen Inc.$238K
  • AbbVie$218K
  • Incyte Corporation$197K
  • Genentech, Inc.$157K
  • Acerta Pharma LLC$154K
  • plus $442K from 18 others
$6,643in research payments, 2019–2025

Across 2 payments — averaging $3321.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$7K
  • Macrogenics, Inc.$143

What the payments were for

  • Travel & lodging$1,70756%
  • Food & beverage$1,29843%
  • Education$231%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few medical oncology providers in Delawareto place this figure against a meaningful peer group, so we don't.

Other medical oncology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →